Webinar 97: Update on cell technology, cell therapy, tissue engineering and gene therapy in Japan
EUBIJ Library & News content
Will Japan take the lead in regenerative medicine, a multi-billion € business? Following the development of iPS cell technology by Professor Shinya Yamanaka, Japan has taken decisive steps to turn this and related research results into business opportunities. Supported by eased regulations and major government programs, Japan now offers a very active research landscape, which includes RIKEN. Many startups have formed, major pharmaceutical firms have initiated R&D in this field, and other...